These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 32795226)

  • 1. Cost-Effectiveness of the International Late Effects of Childhood Cancer Guideline Harmonization Group Screening Guidelines to Prevent Heart Failure in Survivors of Childhood Cancer.
    Ehrhardt MJ; Ward ZJ; Liu Q; Chaudhry A; Nohria A; Border W; Fulbright JM; Mulrooney DA; Oeffinger KC; Nathan PC; Leisenring WM; Constine LS; Gibson TM; Chow EJ; Howell RM; Robison LL; Armstrong GT; Hudson MM; Diller L; Yasui Y; Armenian SH; Yeh JM
    J Clin Oncol; 2020 Nov; 38(33):3851-3862. PubMed ID: 32795226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.
    Wong FL; Bhatia S; Landier W; Francisco L; Leisenring W; Hudson MM; Armstrong GT; Mertens A; Stovall M; Robison LL; Lyman GH; Lipshultz SE; Armenian SH
    Ann Intern Med; 2014 May; 160(10):672-83. PubMed ID: 24842414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects.
    Yeh JM; Nohria A; Diller L
    Ann Intern Med; 2014 May; 160(10):661-71. PubMed ID: 24842413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-Effectiveness.
    Yeh JM; Lowry KP; Schechter CB; Diller LR; O'Brien G; Alagoz O; Armstrong GT; Hampton JM; Hudson MM; Leisenring W; Liu Q; Mandelblatt JS; Miglioretti DL; Moskowitz CS; Nathan PC; Neglia JP; Oeffinger KC; Trentham-Dietz A; Stout NK
    J Natl Cancer Inst; 2022 Feb; 114(2):235-244. PubMed ID: 34324686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
    Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
    J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
    Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
    Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study.
    Yeh JM; Lowry KP; Schechter CB; Diller LR; Alagoz O; Armstrong GT; Hampton JM; Leisenring W; Liu Q; Mandelblatt JS; Miglioretti DL; Moskowitz CS; Oeffinger KC; Trentham-Dietz A; Stout NK
    Ann Intern Med; 2020 Sep; 173(5):331-341. PubMed ID: 32628531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counseling and surveillance of obstetrical risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
    van der Kooi ALF; Mulder RL; Hudson MM; Kremer LCM; Skinner R; Constine LS; van Dorp W; van Dulmen-den Broeder E; Winther JF; Wallace WH; Waugh J; Woodruff TK; Anderson RA; Armenian SH; Bloemenkamp KWM; Critchley HOD; Demoor-Goldschmidt C; Ehrhardt MJ; Green DM; Grobman WA; Iwahata Y; Krishna I; Laven JSE; Levitt G; Meacham LR; Miller ES; Mulders A; Polanco A; Ronckers CM; Samuel A; Walwyn T; Levine JM; van den Heuvel-Eibrink MM
    Am J Obstet Gynecol; 2021 Jan; 224(1):3-15. PubMed ID: 32502557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.
    van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H
    Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
    Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
    Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
    Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
    Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management.
    Bhatt AS; Vaduganathan M; Claggett BL; Fonarow GC; Packer M; Pfeffer MA; Shah SJ; Shen X; Cristino J; McMurray JJV; Solomon SD; Gaziano TA
    JAMA Cardiol; 2023 Nov; 8(11):1041-1048. PubMed ID: 37755814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study.
    de Baat EC; Feijen EAM; Reulen RC; Allodji RS; Bagnasco F; Bardi E; Belle FN; Byrne J; van Dalen EC; Debiche G; Diallo I; Grabow D; Hjorth L; Jankovic M; Kuehni CE; Levitt G; Llanas D; Loonen J; Zaletel LZ; Maule MM; Miligi L; van der Pal HJH; Ronckers CM; Sacerdote C; Skinner R; Jakab Z; Veres C; Haddy N; Winter DL; de Vathaire F; Hawkins MM; Kremer LCM
    J Clin Oncol; 2023 Jan; 41(1):96-106. PubMed ID: 36075007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study.
    Ledwidge MT; O'Connell E; Gallagher J; Tilson L; James S; Voon V; Bermingham M; Tallon E; Watson C; O'Hanlon R; Barry M; McDonald K
    Eur J Heart Fail; 2015 Jul; 17(7):672-9. PubMed ID: 26139583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health Benefits and Cost-Effectiveness of Children's Oncology Group Breast Cancer Screening Guidelines for Chest-Irradiated Hodgkin Lymphoma Survivors.
    Wong FL; Lee JM; Leisenring WM; Neglia JP; Howell RM; Smith SA; Oeffinger KC; Moskowitz CS; Henderson TO; Mertens A; Nathan PC; Yasui Y; Landier W; Armstrong GT; Robison LL; Bhatia S
    J Clin Oncol; 2023 Feb; 41(5):1046-1058. PubMed ID: 36265088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsequent Breast Cancer in Female Childhood Cancer Survivors in the St Jude Lifetime Cohort Study (SJLIFE).
    Ehrhardt MJ; Howell CR; Hale K; Baassiri MJ; Rodriguez C; Wilson CL; Joshi SS; Lemond TC; Shope S; Howell RM; Wang Z; Srivastava D; Mulrooney DA; Zhang J; Robison LL; Ness KK; Hudson MM
    J Clin Oncol; 2019 Jul; 37(19):1647-1656. PubMed ID: 31075046
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.